• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D filed by HTG Molecular Diagnostics Inc.

    8/5/22 6:01:08 AM ET
    $HTGM
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Get the next $HTGM alert in real time by email
    SC 13D 1 g84220sc13d.htm

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13D

    (Rule 13d-101)

     

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

    TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO

    § 240.13d-2(a)

     

    (Amendment No. )1

     

    HTG Molecular Diagnostics, Inc.

    (Name of Issuer)

     

    Common Stock, $0.001 par value

    (Title of Class of Securities)

     

    40434H203

    (CUSIP Number)

     

    Milton C, Ault, III

    BITNILE Holdings, Inc.

    11411 Southern Highlands Parkway, Suite 240

    Las Vegas, NV 89141

    (949) 444-5464

    (Name, Address and Telephone Number of Person

    Authorized to Receive Notices and Communications)

     

    July 26, 2022

    (Date of Event Which Requires Filing of This Statement)

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this Schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ¨.

     

    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See § 240.13d-7 for other parties to whom copies are to be sent.

     

    _______________

    1            The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). 

     

     

     

     - 1 - 

    CUSIP No. 40434H203

     

    1

    NAME OF REPORTING PERSONS

     

    BitNile Holdings, Inc.

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*(a) ¨

    (b) ¨

    3

    SEC USE ONLY

     

    4

    SOURCE OF FUNDS

    WC

    5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e) ¨
    6

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    DELAWARE

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    7

    SOLE VOTING POWER

     

    0

    8

    SHARED VOTING POWER

     

    1,100,000(1)

    9

    SOLE DISPOSITIVE POWER

     

    0

    10

    SHARED DISPOSITIVE POWER

     

    1,100,000(1)

    11

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    1,100,000

    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES¨
    13

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

    9.96%

    14

    TYPE OF REPORTING PERSON

     

    CO

     

    (1)Represents shares of Common Stock held by Digital Power Lending, LLC.

     

     - 2 - 

    CUSIP No. 40434H203

     

    1

    NAME OF REPORTING PERSONS

     

    Digital Power Lending, LLC

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*(a) ¨

    (b) ¨

    3

    SEC USE ONLY

     

    4

    SOURCE OF FUNDS

    WC

    5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e) ¨
    6

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    CALIFORNIA

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    7

    SOLE VOTING POWER

     

    0

    8

    SHARED VOTING POWER

     

    1,100,000

    9

    SOLE DISPOSITIVE POWER

     

    0

    10

    SHARED DISPOSITIVE POWER

     

    1,100,000

    11

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    1,100,000

    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES¨
    13

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

    9.96%

    14

    TYPE OF REPORTING PERSON

     

    OO

     

     - 3 - 

    CUSIP No. 40434H203

     

    1

    NAME OF REPORTING PERSONS

     

    Milton C. Ault, III

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*(a) ¨

    (b) ¨

    3

    SEC USE ONLY

     

    4

    SOURCE OF FUNDS

    AF

    5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e) ¨
    6

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    U.S.A.

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    7

    SOLE VOTING POWER

     

    0

    8

    SHARED VOTING POWER

     

    1,100,000(1)

    9

    SOLE DISPOSITIVE POWER

     

    0

    10

    SHARED DISPOSITIVE POWER

     

    1,100,000(1)

    11

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    1,100,000

    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES¨
    13

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

    9.96%

    14

    TYPE OF REPORTING PERSON

     

    IN

     

    (1)Represents shares of Common Stock held by Digital Power Lending, LLC.

     

     - 4 - 

    CUSIP No. 40434H203

     

    The following constitutes the Schedule 13D filed by the undersigned (the “Schedule 13D”).

     

    Item 1.Security and Issuer.

     

    This statement relates to the Common Stock, $0.001 par value per share (the “Shares”), of HTG Molecular Diagnostics, Inc., a Delaware corporation (the “Issuer”). The address of the principal executive offices of the Issuer is 3430 E. Global Loop, Tucson, AZ 85706.

     

    Item 2.Identity and Background.

     

    (a)This statement is filed by:

     

    (i)BitNile Holdings, Inc., a Delaware corporation, with respect to the Shares beneficially owned by it through its subsidiary Digital Power Lending, LLC;

     

    (ii)Digital Power Lending, LLC, a California limited liability company, with respect to the Shares directly and beneficially owned by it; and

     

    (iii)Milton C. Ault, III, Founder and Executive Chairman of BitNile Holdings, Inc.

     

    Each of the foregoing is referred to as a “Reporting Person” and collectively as the “Reporting Persons.” Each of the Reporting Persons is party to that certain Joint Filing Agreement, attached hereto as Exhibit 99.1. Accordingly, the Reporting Persons are hereby filing a joint Schedule 13D.

     

    Set forth on Schedule A annexed hereto (“Schedule A”) is the name and present principal occupation or employment, principal business address and citizenship of the executive officers and directors of BitNile Holdings, Inc. To the best of the Reporting Persons’ knowledge, except as otherwise set forth herein, none of the persons listed in Schedule A beneficially owns any securities of the Issuer or is a party to any contract, agreement or understanding required to be disclosed herein.

     

    Set forth on Schedule B annexed hereto (“Schedule B”) is the name and present principal occupation or employment, principal business address and citizenship of the executive officers and directors of Digital Power Lending, LLC. To the best of the Reporting Persons’ knowledge, except as otherwise set forth herein, none of the persons listed in Schedule B beneficially owns any securities of the Issuer or is a party to any contract, agreement or understanding required to be disclosed herein.

     

    (b)       The principal business address of BitNile Holdings, Inc. is 11411 Southern Highlands Parkway, Suite 240, Las Vegas, Nevada 89141. The principal business address of Digital Power Lending, LLC is 940 South Coast Drive, Suite 200, Costa Mesa, CA 92626.  The principal business address of Mr. Ault is c/o BitNile Holdings, Inc., 11411 Southern Highlands Parkway, Suite 240, Las Vegas, Nevada 89141. 

     

    (c)        BitNile Holdings, Inc. is a diversified holding company pursuing growth by acquiring undervalued businesses and disruptive technologies with a global impact. Through its wholly and majority-owned subsidiaries and strategic investments, BitNile Holdings owns and operates a data center at which it mines Bitcoin and provides mission-critical products that support a diverse range of industries, including defense/aerospace, industrial, automotive, telecommunications, medical/biopharma, and textiles. The principal business of Digital Power Lending, LLC is investing in securities. The principal occupation of Mr. Ault is serving as the Executive Chairman of BitNile Holdings, Inc. 

     

    (d)       No Reporting Person nor any person listed in Schedules A or B has, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).

     

    (e)       No Reporting Person nor any person listed in Schedules A or B has, during the last five years, been party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

     

     - 5 - 

    CUSIP No. 40434H203

     

    (f)        BitNile Holdings, Inc. is organized under the laws of the State of Delaware. Digital Power Lending, LLC is organized under the laws of the State of California. Mr. Ault is a citizen of the United States of America. The citizenship of the persons listed in Schedules A and B is set forth therein.

     

    Item 3.Source and Amount of Funds or Other Consideration.

     

    The Shares purchased by Digital Power Lending, LLC were purchased with working capital in open market purchases. Digital Power Lending, LLC expended an aggregate of $1,284,529.17 for the purchase of the Shares.

     

    Item 4.Purpose of Transaction.

     

    The Reporting Persons purchased the Shares based on such Reporting Persons’ belief that the Shares, when purchased, were undervalued and represented an attractive investment opportunity. Depending upon overall market conditions, other investment opportunities available to the Reporting Persons, and the availability of Shares at prices that would make the purchase or sale of Shares desirable, the Reporting Persons may endeavor to increase or, eventually, decrease its position in the Issuer through, among other things, the purchase or sale of Shares on the open market or in private transactions or otherwise, on such terms and at such times as such Reporting Persons may deem advisable.

     

    The Reporting Persons have no present plan or proposal which would relate to or result in any of the matters set forth in subparagraphs (a) - (j) of Item 4 of Schedule 13D except as set forth herein or such as would occur upon or in connection with completion of, or following, any of the actions discussed herein. The Reporting Persons intend to review their investment in the Issuer on a continuing basis. Depending on various factors including, without limitation, the Issuer’s financial position and investment strategy, the price levels of the Shares, conditions in the securities markets and general economic and industry conditions, the Reporting Persons may in the future take such actions with respect to their investment in the Issuer as they deem appropriate including, without limitation, engaging in communications with management and the Board of Directors of the Issuer, engaging in discussions with stockholders of the Issuer or other third parties about the Issuer and the Reporting Persons’ investment, including potential business combinations or dispositions involving the Issuer or certain of its businesses, making recommendations or proposals to the Issuer concerning changes to the capitalization, ownership structure, board structure (including board composition), potential business combinations or dispositions involving the Issuer or certain of its businesses, or suggestions for improving the Issuer’s financial and/or operational performance, purchasing additional Shares, selling some or all of its Shares, engaging in short selling of or any hedging or similar transaction with respect to the Shares, including swaps and other derivative instruments, or changing its intention with respect to any and all matters referred to in Item 4.

     

    Item 5.Interest in Securities of the Issuer.

     

    The aggregate percentage of Shares reported owned by each Reporting Person herein is based upon 11,045,986 Shares outstanding, which is the total number of Shares outstanding as of June 21, 2022, as reported in the Issuer’s Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on July 7, 2022.

     

    A.BitNile Holdings, Inc.

     

    (a)As of August 5, 2022, BitNile Holdings, Inc. may be deemed to beneficially own 1,100,000 Shares, consisting of Shares held by Digital Power Lending, LLC. BitNile Holdings, Inc. may be deemed to beneficially own the Shares beneficially owned by Digital Power Lending, LLC by virtue of its relationship with such entity described in Item 2.

     

    Percentage: 9.96%

    (b)1. Sole power to vote or direct vote: 0

    2. Shared power to vote or direct vote: 1,100,000

    3. Sole power to dispose or direct the disposition: 0

    4. Shared power to dispose or direct the disposition: 1,100,000

     

     - 6 - 

    CUSIP No. 40434H203

     

    (c)BitNile Holdings, Inc. has not entered into any transactions in the Shares during the past sixty days.

     

    B.Digital Power Lending, LLC

     

    (a)As of August 5, 2022, Digital Power Lending, LLC beneficially owns 1,100,000 Shares held directly by it.

     

    Percentage: 9.96%

     

    (b)1. Sole power to vote or direct vote: 0

    2. Shared power to vote or direct vote: 1,100,000

    3. Sole power to dispose or direct the disposition: 0

    4. Shared power to dispose or direct the disposition: 1,100,000

     

    (c)The transactions in the Shares by Digital Power Lending, LLC during the past sixty days are set forth in Schedule C and are incorporated herein by reference. All of such transactions were effected in the open market.

     

    C.Milton C. Ault, III

     

    (a)As of August 5, 2022, Mr. Ault may be deemed to beneficially own 1,100,000 Shares, consisting of Shares held by Digital Power Lending, LLC. Mr. Ault may be deemed to beneficially own the Shares beneficially owned by Digital Power Lending, LLC by virtue of his relationship with such entity described in Item 2.

     

    Percentage: 9.96%

     

    (b)1. Sole power to vote or direct vote: 0

    2. Shared power to vote or direct vote: 1,100,000

    3. Sole power to dispose or direct the disposition: 0

    4. Shared power to dispose or direct the disposition: 1,100,000

     

    (c)Mr. Ault has not entered into any transactions in the Shares during the past sixty days.

     

    The filing of this Schedule 13D shall not be deemed an admission that the Reporting Persons are, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, the beneficial owners of any securities of the Issuer that he or it does not directly own. Each of the Reporting Persons specifically disclaims beneficial ownership of the securities reported herein that he or it does not directly own.

     

    (d)No person other than the Reporting Person is known to have the right to receive, or the power to direct the receipt of dividends from, or proceeds from the sale of, the Shares.

     

    (e)Not applicable.

     

     - 7 - 

    CUSIP No. 40434H203

     

    Item 6.Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.

     

    On August 5, 2022, the Reporting Persons entered into a Joint Filing Agreement in which the Reporting Persons agreed to the joint filing on behalf of each of them of statements on Schedule 13D with respect to the securities of the Issuer. A copy of this agreement is attached as an exhibit hereto and is incorporated herein by reference.

     

    Item 7.Material to be Filed as Exhibits.

     

    99.1 Joint Filing Agreement by and among BitNile Holdings, Inc., Digital Power Lending, LLC and Milton C. Ault, III, dated August 5, 2022.

     

     - 8 - 

    CUSIP No. 40434H203

     

    SIGNATURES

     

    After reasonable inquiry and to the best of his knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

     

    Dated:    August 5, 2022

     

     

        BITNILE HOLDINGS, INC.

    /s/ Milton C. Ault, III

         
    MILTON C. AULT, III   By:

    /s/ Milton C. Ault, III

          Name: Milton C. Ault, III
          Title: Executive Chairman

     

     

        DIGITAL POWER LENDING, LLC
           
        By:

    /s/ David J. Katzoff

          Name: David J. Katzoff
          Title: Manager

     

     - 9 - 

    CUSIP No. 40434H203

     

    SCHEDULE A

     

    Officers and Directors of BitNile Holdings, Inc.

     

    Name and Position Principal Occupation Principal Business Address Citizenship

    Milton C. Ault, III

    Executive Chairman

    Executive Chairman of BitNile Holdings, Inc. c/o BitNile Holdings, Inc. 11411 Southern Highlands Parkway, Suite 240, Las Vegas, NV 89141 USA

    William B. Horne

    Chief Executive Officer and Director

    Chief Executive Officer of BitNile Holdings, Inc. c/o BitNile Holdings, Inc. 11411 Southern Highlands Parkway, Suite 240, Las Vegas, NV 89141 USA

    Henry C.W. Nisser

    President, General Counsel and Director

    President and General Counsel of BitNile Holdings, Inc. c/o BitNile Holdings, Inc. 100 Park Avenue, 16th Floor, Suite 1658A, New York, NY 10017 Sweden

    Kenneth S. Cragun

    Chief Financial Officer

    Chief Financial Officer of BitNile Holdings, Inc. c/o BitNile Holdings, Inc. 11411 Southern Highlands Parkway, Suite 240, Las Vegas, NV 89141 USA

    Howard Ash

    Independent Director

    Chairman of Claridge Management c/o BitNile Holdings, Inc. 11411 Southern Highlands Parkway, Suite 240, Las Vegas, NV 89141 USA

    Jeffrey A. Bentz

    Independent Director

    President of North Star Terminal & Stevedore Company c/o BitNile Holdings, Inc. 11411 Southern Highlands Parkway, Suite 240, Las Vegas, NV 89141 USA

    Robert O. Smith

    Independent Director

    Independent Executive Consultant c/o BitNile Holdings, Inc. 11411 Southern Highlands Parkway, Suite 240, Las Vegas, NV 89141 USA

    Moti Rosenberg

    Independent Director

    Independent Consultant c/o BitNile Holdings, Inc. 11411 Southern Highlands Parkway, Suite 240, Las Vegas, NV 89141 Israel

     

     - 10 - 

    CUSIP No. 40434H203

     

    SCHEDULE B

     

    Officers and Directors of Digital Power Lending, LLC

     

    Name and Position Principal Occupation Principal Business Address Citizenship

    David J. Katzoff

    Manager

    Manager of Digital Power Lending, LLC c/o Digital Power Lending, LLC, 940 South Coast Drive, Suite 200, Costa Mesa, CA 92626 USA

     

     - 11 - 

    CUSIP No. 40434H203

     

    SCHEDULE C

     

    Transactions in the Shares of Common Stock During the Last Sixty Days

     

    Digital Power Lending, LLC

     

    Nature of the Transaction Shares of Common Stock
    Purchased / (Sold)
    Price Per
    Share ($)
    Date of
    Transaction
    Purchase of Common Stock 557,000 1.1595 07/26/2022
    Purchase of Common Stock 163,797 1.1300 07/27/2022
    Purchase of Common Stock 1,103 1.1082 07/28/2022
    Purchase of Common Stock 28,100 1.0492 07/29/2022
    Purchase of Common Stock 10,000 1.0956 08/03/2022
    Purchase of Common Stock 340,000 1.2115 08/04/2022

     

     

    - 12 -

     

     

     

    Get the next $HTGM alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $HTGM

    DatePrice TargetRatingAnalyst
    1/7/2022$5.00 → $8.00Hold → Buy
    Craig-Hallum
    More analyst ratings

    $HTGM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Barat Stephen

      4 - HTG MOLECULAR DIAGNOSTICS, INC (0001169987) (Issuer)

      6/9/23 8:11:23 PM ET
      $HTGM
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form 4 filed by Barat Stephen

      4 - HTG MOLECULAR DIAGNOSTICS, INC (0001169987) (Issuer)

      4/7/23 4:16:01 PM ET
      $HTGM
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form 3: New insider Barat Stephen claimed ownership of 1,361 shares

      3 - HTG MOLECULAR DIAGNOSTICS, INC (0001169987) (Issuer)

      2/10/23 4:34:09 PM ET
      $HTGM
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $HTGM
    SEC Filings

    See more
    • HTG Molecular Diagnostics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

      8-K - HTG MOLECULAR DIAGNOSTICS, INC (0001169987) (Filer)

      6/8/23 4:51:32 PM ET
      $HTGM
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • HTG Molecular Diagnostics Inc. filed SEC Form 8-K: Bankruptcy or Receivership, Events That Accelerate or Increase a Direct Financial Obligation, Leadership Update

      8-K - HTG MOLECULAR DIAGNOSTICS, INC (0001169987) (Filer)

      6/5/23 3:42:54 PM ET
      $HTGM
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • HTG Molecular Diagnostics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

      8-K - HTG MOLECULAR DIAGNOSTICS, INC (0001169987) (Filer)

      5/24/23 5:01:07 PM ET
      $HTGM
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $HTGM
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • HTG to Highlight the Advantages of its Drug Discovery Engine at the 2023 BIO International Convention

      TUCSON, Ariz., May 18, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a platform-based life science tools and drug discovery company, today announced that its management team will present the advantages of its proprietary drug discovery engine at the 2023 Biotechnology Innovation Organization (BIO) International Convention and will host in-person meetings during the remaining days of the June 5 – 8, 2023 event in Boston, MA. HTG is pioneering a proprietary platform-based approach that is designed to help improve drug discovery, referred to as transcriptome-informed drug discovery and design. HTG's objective is to develop best-in-class molecules for the treat

      5/18/23 8:00:00 AM ET
      $HTGM
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • HTG Highlights the Advantages of Its Drug Discovery Engine

      TUCSON, Ariz., May 16, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a platform-based life science tools and drug discovery company, today reported achievement of another technical milestone in its drug discovery business. HTG is pioneering a proprietary platform-based approach that is designed to help improve drug discovery, referred to as transcriptome-informed drug discovery and design. HTG's objective is to develop best-in-class molecules for the treatment of diseases, with the ability to apply its platform agnostically across therapy areas. At the center of this approach is HTG's proprietary RNA profiling technologies, functionally married with an adva

      5/16/23 8:47:40 AM ET
      $HTGM
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • HTG Molecular Diagnostics Reports First Quarter 2023 Results and Provides Recent Business Highlights

      TUCSON, Ariz., May 10, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a platform-based life science tools and drug discovery company, today reported financial results for the quarter ended March 31, 2023 and provided recent drug discovery business highlights. HTG has pioneered a proprietary platform-based approach that is designed to help improve drug discovery, referred to as transcriptome-informed drug discovery and design. At the center of this approach is the application of HTG's proprietary RNA profiling technologies, functionally married with advanced medicinal chemistry using a novel artificial intelligence ("AI")-driven platform. This unique drug can

      5/10/23 5:51:27 PM ET
      $HTGM
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $HTGM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • HTG Molecular Diagnostics upgraded by Craig-Hallum with a new price target

      Craig-Hallum upgraded HTG Molecular Diagnostics from Hold to Buy and set a new price target of $8.00 from $5.00 previously

      1/7/22 10:15:02 AM ET
      $HTGM
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SVB Leerink reiterated coverage on HTG Molecular Diagnostics with a new price target

      SVB Leerink reiterated coverage of HTG Molecular Diagnostics with a rating of Outperform and set a new price target of $10.00 from $15.00 previously

      5/14/21 6:42:26 AM ET
      $HTGM
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • HC Wainwright & Co. reiterated coverage on HTG Molecular Diagnostics with a new price target

      HC Wainwright & Co. reiterated coverage of HTG Molecular Diagnostics with a rating of Buy and set a new price target of $9.00 from $11.00 previously

      5/14/21 6:28:53 AM ET
      $HTGM
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $HTGM
    Financials

    Live finance-specific insights

    See more
    • HTG Announces Certain Preliminary 2022 Unaudited Financial Results

      Preliminary full year 2022 unaudited revenue of $6.4 million Cash and cash equivalents of $12.2 million as of December 31, 2022 TUCSON, Ariz., Jan. 06, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling and advanced medicinal chemistry technology, today announced certain preliminary, unaudited financial results for the year ended December 31, 2022. Total revenue for the full year 2022 is expected to be approximately $6.4 million, including approximately $2.7 million of HTG Transcriptome Panel (HTP) revenue representing 42% of our total revenue. Cash and cash

      1/6/23 8:00:00 AM ET
      $HTGM
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • HTG Molecular Diagnostics Reports Second Quarter 2022 Results

      TUCSON, Ariz., Aug. 11, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today reported recent business highlights and financial results for the quarter ended June 30, 2022. Throughout the quarter ended June 30, 2022, the Company's technology and strategic development efforts were highlighted in a number of customer and KOL presentations and publications including, but not limited to, the following: A webinar titled "Integration of the HTG Transcriptome Panel into Preclinical and Clinical Programs to Drive Precision Medicine Research" fe

      8/11/22 4:05:00 PM ET
      $HTGM
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • HTG Molecular Diagnostics to Announce Q2 2022 Financial Results and Host Conference Call on Thursday, August 11

      TUCSON, Ariz., Aug. 04, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced that it will report its financial results for the quarter ended June 30, 2022 after the market close on Thursday, August 11, 2022. Management will also host a conference call with investors to discuss financial results and provide a corporate update at 4:30pm Eastern Time. Details for the conference call are as follows: Conference Call & Webcast Details Date:Thursday, August 11Time:4:30pm ETToll Free:1-800-954-0602 International:1-212-231-2936 Conference ID:2

      8/4/22 8:00:00 AM ET
      $HTGM
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $HTGM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by HTG Molecular Diagnostics Inc. (Amendment)

      SC 13G/A - HTG MOLECULAR DIAGNOSTICS, INC (0001169987) (Subject)

      2/13/23 3:33:23 PM ET
      $HTGM
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form SC 13G/A filed by HTG Molecular Diagnostics Inc. (Amendment)

      SC 13G/A - HTG MOLECULAR DIAGNOSTICS, INC (0001169987) (Subject)

      2/10/23 9:03:52 AM ET
      $HTGM
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form SC 13G filed by HTG Molecular Diagnostics Inc.

      SC 13G - HTG MOLECULAR DIAGNOSTICS, INC (0001169987) (Subject)

      2/3/23 4:02:18 PM ET
      $HTGM
      Biotechnology: Laboratory Analytical Instruments
      Industrials